Areas of Interest
As of 12/28/18. See Astellas Partnerships.
Oncology
- Genitourinary Malignancy treated by either urologists or medical oncologists
- Hematologic Oncology, especially products with the potential to ultimately be prescribed by the hematologists treating AML
- Immuno-oncology approaches that would supplement our growing pipeline
- Agents with demonstrated clinical activity based on innovative approaches
- Core research technologies that would expand our capabilities
Urology
- Underactive Bladder
- Nocturia and Nocturnal Polyuria
- Stress Urinary Incontinence
- Interstitial cystitis/bladder pain syndrome
Nephrology
- Acute Kidney Injury
Immunology
- Systemic Lupus erythematosus
- Systemic sclerosis
- Celiac disease
- Allergie
Neuroscience
- Treatments that (1) target cognitive impairment associated with schizophrenia and cognitive impairment associated with psychotic bipolar disorder, (2) prevent or attenuate the emergence of schizophrenia or psychotic bipolar disorders, (3) treatments for Negative Symptoms in Schizophrenia
- Genetics- and pathophysiology-based novel therapies
Neuromuscular
- Novel therapies including gene/cell therapies in neuromuscular diseases
- Improvement of muscle functions in non-neuromuscular diseases with aging, cachexia, disuse conditions, chronic organ diseases major surgery and intensive care.
- Drug delivery technologies which enable muscle-directed delivery
Ophthalmology
- Back of the eye diseases (AMD, DME, inherited retinal diseases, glaucomatic optic neuropathy….)
- New modalities including cell therapy and gene therapy
Regenerative Medicine
- PSC-derived cell products for patients with high unmet needs
- Technology to manufacture cell products safe and efficiently
Infectious Disease
- Healthcare Associated Infection (HAI) vaccines (Gram negative bacteria and others)
- Vaccines against virus infections (RSV, CMV, Norovirus and others)
- Vaccines for refractory infection
Gene Therapy
- In vivo gene therapy
- AAV
- Oncolytic Virus
- As therapeutic area, Sensory diseases, CNS, Muscle disorders, Cancer
- Genome editing